только для медицинских специалистов

Консультант врача

Электронная медицинская библиотека

Раздел 12 / 12
Страница 1 / 1

Литература

  1. Lancellotti P, Price S, Edvardsen T, et al. The use of echocardiography in acute cardiovascular care: recommendations of the European Association of Cardiovascular Imaging and the Acute Cardiovascular Care Association. Eur Heart J Cardiovasc Imaging. 2015;16:119-46.
  2. Cardim N, Dalen H, Voigt JU, et al. The use of handheld ultrasound devices: a position statement of the European Association of Cardiovascular Imaging (2018 update). Eur Heart J Cardiovasc Imaging. 2019;20(3):245-52. doi:10.1093/ehjci/ jey145.
  3. Приказ Министерства здравоохранения Российской Федерации от 08.06.2020 г. № 557н “Об утверждении Правил проведения ультразвуковых исследований”.
  4. Nielsen MB. Handheld Ultrasound devices (HHUSD): A short review of the equipment available on the market as of September 2017. Ultraschall in Med. 2017;38:668-74. doi:10.1055/s-007-35902.
  5. Mjolstad OC, Dalen H, Graven T, et al. Routinely adding ultrasound examinations by pocket-sized ultrasound devices improves inpatient diagnostics in a medical department. Eur J Intern Med. 2012;23:185-91. doi:10.1016/j.ejim.2011.10.009.
  6. Mirabel M, Celermajer D, Beraud A-S, et al. Pocket-sized focused cardiac ultrasound: strengths and limitations. Arch Cardiovasc Dis. 2015;108:197-205. doi:10.1016/j.acvd.2015.01.002.
  7. Spencer KT, Kimura BJ, Korcarz CE, et al. Focused Cardiac Ultrasound: Recommendations from the American Society of Echocardiography. J. Am. Soc. Echocardiogr. 2013;26(6):567-81.
  8. Neskovic AN, Skinner H, Price S, et al. Reviewers: This document was reviewed by members of the 2016–2018 EACVI Scientific Documents Committee. Focus cardiac ultrasound core curriculum and core syllabus of the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2018;19(5):475-81. doi:10.1093/ehjci/jey006.
  9. Escher F, Kasner M, Kühl U, et al. New echocardiographic findings correlate with intramyocardial inflammation in endomyocardial biopsies of patients with acute myocarditis and inflammatory cardiomyopathy. Mediators Inflamm. 2013;2013:875420. doi:10.1155/2013/875420.
  10. Moore CL, Copel JA. Point-of-care ultrasonography. N Engl J Med. 2011;364(8):749-57. doi:10.1056/NEJMra0909487.
  11. Mandavia DP, Hoffner RJ, Mahaney K, Henderson SO. Bedside echocardiography by emergency physicians. Ann Emerg Med. 2001;38(4):377-82. doi:10.1067/ mem.2001.118224.5.
  12. Torres-Macho J, Antón-Santos JM, García-Gutierrez I, et al. Initial accuracy of bedside ultrasound performed by emergency physicians for multiple indications after a short training period. Am J Emerg Med. 2012;30(9):1943-9. doi:10.1016/j. ajem.2012.04.015.
  13. Moore CL, Rose GA, Tayal VS, et al. Determination of left ventricular function by emergency physician echocardiography of hypotensive patients. Acad Emerg Med. 2002;9(3):186-93. doi:10.1111/j.1553-2712.2002.tb00242.x.
  14. Randazzo MR, Snoey ER, Levitt MA, Binder K. Accuracy of emergency physician assessment of left ventricular ejection fraction and central venous pressure using echocardiography. Acad Emerg Med. 2003;10(9):973-77. doi:10.1111/j.1553-2712.2003.tb00654.x.
  15. Hoffmann M, Kleine-Weber H, Schroeder S. SARS-CoV-2 Cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181(2):271-80.e8.
  16. World Health Organization Coronavirus disease (COVID-19) situation report–209. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situationreports/ Available at: Accessed: September 7, 2020.
  17. COVID-19 Coronavirus Pandemic World o meter. https://www.worldometers.info/ coronavirus/?utm_campaign=homeAdUOA?Si Available at. Accessed September 7, 2020.
  18. Santoso A, Pranata R, Wibowo A. Cardiac injury is associated with mortality and critically ill pneumonia in COVID-19: a meta-analysis. Am J Emerg Med. 2020;S0735-6757(20):30280-1.
  19. Fehr AR, Channappanavar R, Perlman S. Middle east respiratory syndrome: emergence of a pathogenic human coronavirus. Annu Rev Med. 2017;68:38799.
  20. Hamming I, Timens W, Bulthuis ML. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. 2004;203(2):631-7.
  21. Tai W, He L, Zhang X. Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine. Cell Mol Immunol. 2020;17(6):613-20.
  22. Li W, Moore MJ, Vasllieva N. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature. 2003;426(6965):450-4.
  23. Zhou P, Yang XL, Wang XG. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579(7798):270-3.
  24. Ge XY, Li JL, Yang XL. Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor. Nature. 2013;503:535-8.
  25. Zhang H, Penninger JM, Li Y. Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Med. 2020;46(4):586-90.
  26. Kuba K, Imai Y, Rao S. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat Med. 2005;11(8):875-9.
  27. Huang C, Wang Y, Li X. Clinical features of patients infected with 2019 novel coronavirus in Wuhan. China Lancet. 2020;395(10223):497-506.
  28. Branchford BR, Carpenter SL. The role of inflammation in venous thromboembolism. Front Pediatr. 2018;6:142.
  29. Kwong JC, Schwartz KL, Campitelli MA. Acute myocardial infarction after laboratory- confirmed influenza infection. N Engl J Med. 2018;378:345-53.
  30. Driggin E, Madhavan MV, Bikdeli B. Cardiovascular considerations for patients, health care workers, and health systems during the COVID-19 pandemic. J Am Coll Cardiol. 2020;75(18):2352-71.
  31. Guo T, Fan Y, Chen M. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19) JAMA Cardiol. 2020;5(7):811-8.
  32. Bangalore S, Sharma A, Slotwiner A. ST-segment elevation in patients with Covid-19 — a case series. N Engl J Med. 2020;382(25):2478-80.
  33. Tavazzi G, Pellegrini C, Maurelli M. Myocardial localization of coronavirus in COVID-19 cardiogenic shock. Eur J Heart Fail. 2020;22(5):911-5.
  34. Guzik TJ, Mohiddin SA, Dimarco A. COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options. Cardiovasc Res. 2020;116(10):1666-87.
  35. Siddiqi HK, Mehra MR. COVID-19 illness in native and immunosuppressed states: a clinical-therapeutic staging proposal. J Heart Lung Transplant. 2020;39:405-7. doi:10.1016/j.healun.2020.03.012.
  36. Welt F. G. P., Shah P. B., Aronow H. D. Catheterization laboratory considerations during the coronavirus (COVID-19) pandemic: from the ACC’s interventional council and SCAI. J Am Coll Cardiol. 2020;75(18):2372–2375.
  37. Prinz C, Dohrmann J, van Buuren F. et al. Diagnostic performance of handheld echocardiography for the assessment of basic cardiac morphology and function: a validation study in routine cardiac patients. Echocardiography 2012; 29: 887-894. doi: 10.1111/j.1540-8175.2012.01728.x
  38. J. N. Kirkpatrick et al., “Recommendations for Echocardiography Laboratories Partic ipating in Cardiac Point of Care Cardiac Ultrasound (POCUS) and Critical Care Echocardiography Training: Report from the American Society of Echocar- diography,” J. Am. Soc. Echocardiogr., vol. 33, no. 4, pp. 409-422.e4, Apr. 2020.
  39. Afonso L, Hari P, Pidlaoan V, et al. Acute myocarditis: Can novel echocardiographic techniques assist with diagnosis? Eur J Echocardiogr. 2010;11:E5.
  40. Bossone E, Lyon A, Citro R, et al. Takotsubo cardiomyopathy: An integrated multi- imaging approach. Eur Heart J Cardiovasc Imaging. 2014;15:366-77.
  41. Hurst R, Prasad A, Askew J, et al. Takotsubo cardiomyopathy: A unique cardiomyopathy with variable ventricular morphology. JACC Cardiovasc Imaging. 2010;3:641-9.
  42. Hagan P, Nienaber C, Isselbacher E, et al. The International Registry of Acute Aortic Dissection (IRAD): New insights into an old disease. JAMA. 2000;283:897903.
  43. Flachskampf FA, Wouters PF, Edvardsen T, et al. Transoesophageal echo cardiography: EACVI update 2014. Eur Heart J Cardiovasc Imaging. 2014;15:353-65.
  44. Nienaber CA, von Kodolitsch Y, Nicolas V, et al. The diagnosis of thoracic aortic dissection by noninvasive imaging procedures. N Engl J Med. 1993;328:1-9.
  45. Erbel R, Oelert H, Meyer J, et al. Effect of medical and surgical therapy on aortic dissection evaluated by transesophageal echocardiography. Implications for pro- gnosis and therapy. The European Cooperative Study Group on Echocardiography. Circulation. 1993;87:1604-15.
  46. Kim SH, Song JM, Jung IH, et al. Initial echocardiographic characteristics of pericardial effusion determine the pericardial complications. Int J Cardiol. 2009;136:151-5.
  47. Lodigiani C, Iapichino G, Carenzo L. Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy. Thromb Res. 2020;191:9-14.
  48. Cui S, Chen S, Li X, et al. Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. J Thromb Haemost. 2020;18(6):1421-4.
  49. Klok FA, Kruip MJHA, van der Meer NJM. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020;191:145-7.
  50. Konstantinides SV, Torbicki A, Agnelli G, et al. 2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism: thetask force for the diagnosis and management of acute pulmonary embolism ofthe European Society of Cardiology (ESC). Endorsed by the European Respiratory Society (ERS). Eur Heart J. 2014;35:3033-73.
  51. Roy PM, Friou E, Germeau B, et al. Derivation and Validation of a 4-Level Clinical Pretest Probability Score for Suspected Pulmonary Embolism to Safely Decrease Imaging Testing. JAMA Cardiol. 2021;6(6):669-77. doi:10.1001/ jamacardio.2021.0064.
  52. Pollack CV, Schreiber D, Goldhaber SZ, et al. Clinical characteristics, management, and outcomes of patients diagnosed with acute pulmonary embolism in the emergency department: initial report of EMPEROR (Multicenter Emergency Medicine Pulmonary Embolism in the Real World Registry). J Am Coll Cardiol. 2011;57(6):700-6. doi:10.1016/j.jacc.2010.05.071.
  53. Wicki J, Perneger TV, Junod AF, et al. Assessing clinical probability of pulmonary embolism in the emergency ward: a simple score. Arch Intern Med. 2001;161(1):927. doi:10.1001/archinte.161.1.92.
  54. Wells PS, Anderson DR, Rodger M, et al. Excluding pulmonary embolism at the bedside without diagnostic imaging: management of patients with suspected pulmonary embolism presenting to the emergency department by using a simple clinical model and d-dimer. Ann Intern Med. 2001;135(2):98-107. doi:10.7326/ 0003-4819-135-2-200107170-00010.
  55. Douma RA, Gibson NS, Gerdes VE, et al. Validity and clinical utility of the simplified Wells rule for assessing clinical probability for the exclusion of pulmonary embolism. Thromb Haemost. 2009;101(1):197-200.